News & Updates

In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.

Utility of pituitary transcription factors (TFs) improves the diagnostic accuracy and prognostication of nonfunctioning pituitary neuroendocrine tumours (NF-PitNETs), according to local data and a new diagnostic classification presented at the 5^th Annual Meeting of Endocrinology, Diabetes & Metabolism Hong Kong (EDM HK).

Vegan and vegetarian diets that are low in carbohydrates reduce body weight as well as improve glycaemic control and blood pressure in individuals with type 2 diabetes (T2D), suggests a study, adding that a plant-based diet shows greater potential decrease in greenhouse gas emissions.

Use of glucagon-like peptide 1 (GLP-1) receptor agonists or sodium-glucose co-transporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, helps prevent severe exacerbations of chronic obstructive pulmonary disease (COPD) in patients with type 2 diabetes (T2D), a UK study has shown.

Crucial gaps remain between the perspectives of patients living with type 2 diabetes and healthcare providers, a recent study has found.

Once-weekly treatment with semaglutide, when administered with lifestyle intervention, leads to greater reduction in body mass index among adolescents with obesity as compared with lifestyle intervention alone, as shown in the STEP TEENS study.